Skip to main
HUM

Humana (HUM) Stock Forecast & Price Target

Humana (HUM) Analyst Ratings

Based on 19 analyst ratings
Hold
Strong Buy 16%
Buy 21%
Hold 53%
Sell 5%
Strong Sell 5%

Bulls say

Humana is a strong performer in the private health insurance space, with a focus on lucrative government-sponsored programs. Their aggressive growth strategy for the individual Medicare Advantage plans is paying off, with estimated 25% year-over-year growth and steady enrollment. Despite potential challenges like mortality and legislative risks, Humana's results have been impressive thus far, with strong quarterly earnings, efficient cost management, and a promising outlook for the future. Overall, Humana presents a favorable investment opportunity in the healthcare sector with potential for steady revenue growth and reasonable valuation.

Bears say

Humana is heavily reliant on its government-sponsored programs, which comprise nearly all of its medical membership and are subject to potential margin contraction. Despite some margin expansion potential in CY27 and CY28, the company may struggle to achieve its target margin of 3.0%, which casts doubt on its future earnings potential and justifies a negative outlook.

Humana (HUM) has been analyzed by 19 analysts, with a consensus rating of Hold. 16% of analysts recommend a Strong Buy, 21% recommend Buy, 53% suggest Holding, 5% advise Selling, and 5% predict a Strong Sell.

This aggregate rating is based on analysts' research of Humana and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Humana (HUM) Forecast

Analysts have given Humana (HUM) a Hold based on their latest research and market trends.

According to 19 analysts, Humana (HUM) has a Hold consensus rating as of Aug 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $358.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $358.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Humana (HUM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.